This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Washington (UW) to provide QRT-PCR testing analysis services. The contract has a ceiling value of $194,400.00 and a period of performance ending August 18, 2025. The contract does not have a set-aside designation. UW is a leading research university that has received numerous prime federal contract and grant awards to support a...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $196,668.00 firm fixed price purchase order to the University of Washington (UW) for Quantitative Reverse Transcription Polymerase Chain Reaction (QRT-PCR) testing analysis services. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025 with no set-aside designation. UW is a leading research university that has received numerous prime federal contract and grant awards to...
The University of Washington School of Medicine, doing business as the University of Washington Department of Laboratory Medicine, has been awarded a firm-fixed price purchase order by the National Institute of Allergy and Infectious Diseases to provide QRT-PCR testing analysis services on malaria samples. The award has a ceiling value of $149,999.71 and an ultimate completion date of August 14, 2024. This contract is not set aside for small businesses. As a leading medical school and research...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $249,900.00 firm fixed price purchase order contract to the University of Washington School of Medicine for laboratory testing services in support of a malaria study in Mali. The contract has a completion date of January 4, 2024. The University of Washington School of Medicine is the prime contractor and is a U.S. state government entity. No set-aside...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Washington (UW) to ensure standardization and comparability of functional genomics services and assays conducted for the NIAID Simian Vaccine Evaluation Units and Division of AIDS (DAIDS)-supported preclinical nonhuman primate studies. The contract has a ceiling value of $17,317,765.02 and a period...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Washington School of Medicine. The $23,012,457.00 firm-fixed-price contract is for specialized biomedical services and laboratory testing to support federal healthcare and research initiatives. The School of Medicine, which is a part of the University of Washington, has extensive expertise in clinical pathology,...
This federal contract award, valued at $32,396.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to the University of Washington School of Medicine, doing business as the University of Washington Department of Laboratory Medicine. The contract, which is a firm-fixed price purchase order, is for Immunoplex Sequencing services. The award was made on a sole-source basis, as NIAID determined that the University of...
This is a $240,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) for EXOME SEQUENCING ANALYST SUPPORT services. The award has an ultimate completion date of April 21, 2025. UW is a large public research university that frequently competes for and wins federal contract and grant awards across various scientific and technological domains. This contract is not set aside. UW has significant experience providing...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Washington (UW). The contract, valued at $7,822,728.37, is for biomedical research services under the Population Genetics Analysis Program. The contract is a definitive, cost-no-fee type and does not have a set-aside designation. UW is a leading public research university that has extensive experience in supporting federal agencies through prime contract and grant...
This firm-fixed price purchase order was awarded by the National Institutes of Health (NIH) to the University of Washington School of Medicine, doing business as the University of Washington Department of Laboratory Medicine, for specialized laboratory testing services. The award, valued at $136,982.13, supports the University of Washington's provision of toxicology, molecular biology, microbiology, virology, and oncology testing to various federal agencies, including the Department of...